Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 108

1.

Can we predict new AF occurrence in single-chamber ICD patients? Insights from an observational investigation.

Biffi M, Ziacchi M, Ricci RP, Facchin D, Morani G, Landolina M, Lunati M, Iacopino S, Capucci A, Bianchi S, Infusino T, Botto GL, Padeletti L, Boriani G.

Int J Cardiol. 2016 Dec 22. pii: S0167-5273(16)34617-4. doi: 10.1016/j.ijcard.2016.12.126. [Epub ahead of print]

PMID:
28041702
2.

The increased risk of stroke/transient ischemic attack in women with a cardiac implantable electronic device is not associated with a higher atrial fibrillation burden.

Boriani G, Lip GY, Ricci RP, Proclemer A, Landolina M, Lunati M, Padeletti L, Zanotto G, Molon G, Biffi M, Rordorf R, Quartieri F, Gasparini M.

Europace. 2016 Dec 28. pii: euw333. doi: 10.1093/europace/euw333. [Epub ahead of print]

PMID:
28031277
3.

Multipoint Pacing versus conventional ICD in Patients with a Narrow QRS complex (MPP Narrow QRS trial): study protocol for a pilot randomized controlled trial.

Gasparini M, Galimberti P, Bragato R, Ghio S, Raineri C, Landolina M, Chieffo E, Lunati M, Mulargia E, Proclemer A, Facchin D, Rordorf R, Vicentini A, Marcantoni L, Zanon F, Klersy C.

Trials. 2016 Dec 3;17(1):572.

4.

Pulmonary Vein Isolation with the Cryoballoon Technique: Feasibility, Procedural Outcomes, and Adoption in the Real World: Data from One Shot Technologies TO Pulmonary Vein Isolation (1STOP) Project.

Padeletti L, Curnis A, Tondo C, Lunati M, Porcellini S, Verlato R, Sciarra L, Senatore G, Catanzariti D, Leoni L, Landolina M, Delise P, Iacopino S, Pieragnoli P, Arena G.

Pacing Clin Electrophysiol. 2016 Nov 10. doi: 10.1111/pace.12975. [Epub ahead of print]

PMID:
27862043
5.

Different impact of long-detection interval and anti-tachycardia pacing in reducing unnecessary shocks: data from the ADVANCE III trial.

Arenal A, Proclemer A, Kloppe A, Lunati M, Mart├Čnez Ferrer JB, Hersi A, Gulaj M, Wijffels MC, Santi E, Manotta L, Mangoni L, Gasparini M.

Europace. 2016 Nov;18(11):1719-1725.

PMID:
27485577
6.

Prognostic implications of mitral regurgitation in patients after cardiac resynchronization therapy.

Cipriani M, Lunati M, Landolina M, Proclemer A, Boriani G, Ricci RP, Rordorf R, Matassini MV, Padeletti L, Iacopino S, Molon G, Perego GB, Gasparini M; Italian ClinicalService Project Investigators..

Eur J Heart Fail. 2016 Aug;18(8):1060-8. doi: 10.1002/ejhf.569.

PMID:
27412374
7.

Assessment of Groin Application of Junctional Tourniquets in a Manikin Model.

Kragh JF, Lunati MP, Kharod CU, Cunningham CW, Bailey JA, Stockinger ZT, Cap AP, Chen J, Aden JK, Cancio LC.

Prehosp Disaster Med. 2016 Aug;31(4):358-63. doi: 10.1017/S1049023X16000443.

PMID:
27230520
8.

Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view.

Disertori M, Gulizia MM, Casolo G, Delise P, Di Lenarda A, Di Tano G, Lunati M, Mestroni L, Salerno-Uriarte J, Tavazzi L.

J Cardiovasc Med (Hagerstown). 2016 Apr;17(4):245-55. doi: 10.2459/JCM.0000000000000368. Review.

9.

Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.

Lunati M, Proclemer A, Boriani G, Landolina M, Locati E, Rordorf R, Daleffe E, Ricci RP, Catanzariti D, Tomasi L, Gulizia M, Baccillieri MS, Molon G, Gasparini M; ClinicalService Cardiological Centres..

Europace. 2016 Sep;18(9):1391-8. doi: 10.1093/europace/euv420.

PMID:
26826135
11.

Basal and stimulated calcitonin levels in patients with type 2 diabetes did not change during 1 year of Liraglutide treatment.

Lunati ME, Grancini V, Colombo C, Palmieri E, Resi V, Perrino M, Orsi E, Fugazzola L.

Metabolism. 2016 Jan;65(1):1-6. doi: 10.1016/j.metabol.2015.09.010.

PMID:
26683791
12.

[Remarks on polyparametric assessment of sudden death risk for primary prevention ICD implantation in patients with left ventricular dysfunction of ischemic and non ischemic etiology. Italian Association of Hospital Cardiologists (ANMCO) Experts Position Paper].

Disertori M, Gulizia MM, Casolo G, Delise P, Di Lenarda A, Di Tano G, Lunati M, Mestroni L, Salerno-Uriarte JA, Tavazzi L.

G Ital Cardiol (Rome). 2015 Nov;16(11):651-66. doi: 10.1714/2066.22442. Italian.

PMID:
26571481
13.

The Economic Impact of The use of Implantable Cardioverter Defibrillator In Primary Prevention.

Madotto F, Conti S, Chiodini V, Mantovani LG, Achilli F, Curnis A, Landolina M, Lunati M, Marzegalli M, Proclemer A, Fornari C, Cesana G.

Value Health. 2015 Nov;18(7):A337. doi: 10.1016/j.jval.2015.09.122. No abstract available.

14.

External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR-Flash study.

Locati ET, Moya A, Oliveira M, Tanner H, Willems R, Lunati M, Brignole M.

Europace. 2016 Aug;18(8):1265-72. doi: 10.1093/europace/euv311.

15.

Ventricular antitachycardia pacing therapy in patients with heart failure implanted with a cardiac resynchronization therapy defibrillator device: Efficacy, safety, and impact on mortality.

Landolina M, Lunati M, Boriani G, Pietro Ricci R, Proclemer A, Facchin D, Rordorf R, Morani G, Maines M, Gasparini G, Molon G, Turrini P, Gasparini M; ClinicalService cardiological centers..

Heart Rhythm. 2016 Feb;13(2):472-80. doi: 10.1016/j.hrthm.2015.10.022.

PMID:
26477710
16.

Contribution of ╬▓-cell dysfunction and insulin resistance to cirrhosis-associated diabetes: Role of severity of liver disease.

Grancini V, Trombetta M, Lunati ME, Zimbalatti D, Boselli ML, Gatti S, Donato MF, Resi V, D'Ambrosio R, Aghemo A, Pugliese G, Bonadonna RC, Orsi E.

J Hepatol. 2015 Dec;63(6):1484-90. doi: 10.1016/j.jhep.2015.08.011.

PMID:
26297917
17.

1A.08: GENETIC MARKERS IN CARDIAC RESYNCHRONIZATION THERAPY TREATMENT SUCCESS.

Schmitz B, De Maria R, Gatsios D, Chrysanthakopoulou T, Landolina M, Gasparini M, Campolo J, Parolini M, Sanzo A, Galimberti P, Lenders M, Brand E, Parodi O, Lunati M, Brand SM.

J Hypertens. 2015 Jun;33 Suppl 1:e3. doi: 10.1097/01.hjh.0000467358.81839.de.

PMID:
26102783
18.

Validation of a simple risk stratification tool for patients implanted with Cardiac Resynchronization Therapy: the VALID-CRT risk score.

Gasparini M, Klersy C, Leclercq C, Lunati M, Landolina M, Auricchio A, Santini M, Boriani G, Proclemer A, Leyva F.

Eur J Heart Fail. 2015 Jul;17(7):717-24. doi: 10.1002/ejhf.269.

19.

Assessment of a standardized algorithm for cardiac pacing in older patients affected by severe unpredictable reflex syncopes.

Brignole M, Ammirati F, Arabia F, Quartieri F, Tomaino M, Ungar A, Lunati M, Russo V, Del Rosso A, Gaggioli G; Syncope Unit Project (SUP) Two Investigators..

Eur Heart J. 2015 Jun 21;36(24):1529-35. doi: 10.1093/eurheartj/ehv069.

20.

Cumulative analysis on 4802 patients confirming that women benefit more than men from cardiac resynchronization therapy.

Cipriani M, Ammirati E, Landolina M, Oliva F, Ghio S, Rordorf R, Lunati M.

Int J Cardiol. 2015 Mar 1;182:454-6. doi: 10.1016/j.ijcard.2015.01.028. No abstract available.

PMID:
25602298
Items per page

Supplemental Content

Loading ...
Support Center